Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd is listed in filings as 10% Owner at Ovid Therapeutics Inc.. This profile follows SEC Form 4 activity through Dec 9, 2025, including 3 public disclosures. Recent filings connect the profile to Ovid Therapeutics Inc. (OVID) and HilleVax, Inc. (HLVX). The current snapshot covers public activity from Sep 19, 2025 to Dec 9, 2025. Reported amounts are shown as $13.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.